McKesson Corporation (NYSE:MCK – Get Free Report) announced a quarterly dividend on Tuesday, July 21st. Investors of record on Tuesday, September 1st will be paid a dividend of 0.94 per share on Thursday, October 1st. This represents a c) annualized dividend and a yield of 0.5%. The ex-dividend date of this dividend is Tuesday, September 1st. This is a 14.6% increase from McKesson’s previous quarterly dividend of $0.82.
McKesson has raised its dividend payment by an average of 0.1%annually over the last three years and has raised its dividend every year for the last 17 years. McKesson has a dividend payout ratio of 7.8% meaning its dividend is sufficiently covered by earnings. Research analysts expect McKesson to earn $49.96 per share next year, which means the company should continue to be able to cover its $3.28 annual dividend with an expected future payout ratio of 6.6%.
McKesson Stock Down 1.8%
NYSE:MCK traded down $14.89 during trading hours on Wednesday, reaching $813.95. The company had a trading volume of 710,477 shares, compared to its average volume of 942,314. The stock has a 50-day moving average of $775.33 and a two-hundred day moving average of $838.48. McKesson has a one year low of $637.00 and a one year high of $999.00. The firm has a market capitalization of $95.30 billion, a PE ratio of 21.16, a PEG ratio of 1.37 and a beta of 0.31.
About McKesson
McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.
The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.
Recommended Stories
- Five stocks we like better than McKesson
- Could Truth API Become Trump Media’s First Meaningful Revenue Driver?
- Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying
- Moog Is More Than a Missile Maker, and Wall Street Is Noticing
- A Boring Dividend Growth Strategy Becomes a Solid Defensive Play
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.
